Drug-induced hyperuricaemia and gout.
Ben Salem C, Slim R, Fathallah N, Hmouda H.
Rheumatology (Oxford). 2017 May 1;56(5):679-688. doi: 10.1093/rheumatology/kew293.
Drug-Induced Hypouricemia.
Ben Salem C, Agrebi M, Sahnoun D, Fathallah N, Hmouda H.
Drug Saf. 2025 Feb;48(2):129-142. doi: 10.1007/s40264-024-01485-7. Epub 2024 Sep 17.
[Drug-induced hyperuricemia].
Hamada T, Hisatome I, Shigemasa C.
Nihon Rinsho. 2003 Jan;61 Suppl 1:333-7.
Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system.
Zheng G, Lu M, Ouyang Y, Chen S, Hu B, Xu S, Sun G.
Sci Rep. 2025 Jul 2;15(1):22856. doi: 10.1038/s41598-025-06114-6.
Drug-induced gout.
Scott JT.
Baillieres Clin Rheumatol. 1991 Apr;5(1):39-60. doi: 10.1016/s0950-3579(05)80295-x.
[Drug-induced hyperuricemia with decreased renal excretion of urate].
Hosoya T, Ikeda H, Ichida K, Tabe A, Sakai O.
Nihon Rinsho. 1991 May;49(5):1060-4.
Gout Medications.
[No authors listed]
2017 Jul 19. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Febuxostat-induced hepatocellular injury.
Lin J, Braxton D, Fong TL.
BMJ Case Rep. 2025 Aug 31;18(8):e266332. doi: 10.1136/bcr-2025-266332.
Altered Serum Uric Acid Levels in Kidney Disorders.
Kim GH, Jun JB.
Life (Basel). 2022 Nov 15;12(11):1891. doi: 10.3390/life12111891.
Allopurinol-induced Sweet's syndrome.
Polimeni G, Cardillo R, Garaffo E, Giardina C, Macrì R, Sirna V, Guarneri C, Arcoraci V.
Int J Immunopathol Pharmacol. 2016 Jun;29(2):329-32. doi: 10.1177/0394632015599705. Epub 2015 Dec 18.
